Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Journal of Cataract and Refractive Surgery
|
May 1, 2007
Prophylactic gatifloxacin therapy in prevention of bacterial keratitis in a rabbit laser in situ keratomileusis model
D Snow Slade, Jason W Friday, Robert W Snyder, et al.
The Annals of Pharmacotherapy
|
May 4, 2006
Estimation of creatinine clearance in end-stage liver disease
David E Nix, Brian L Erstad, Paul Z Nakazato, et al.
Avicenna Journal of Medicine
|
August 13, 2019
Overprescription of antibiotics in patients with community-acquired pneumonia in the intensive care unit
Rorak Hooten, Jose Luis Marquez, Kady Goldlist, et al.
American Journal of Infection Control
|
April 4, 2018
Influenza vaccine availability at urgent care centers in the state of Arizona
Norman L Beatty, Kelly M Hager, Kyle R McKeown, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
September 8, 2007
End-of-procedure cefazolin concentrations after administration for prevention of surgical-site infection
Erin Koopman, David E Nix, Brian L Erstad, et al.
The Journal of Infectious Diseases
|
January 15, 2014
Modeling nikkomycin Z dosing and pharmacology in murine pulmonary coccidioidomycosis preparatory to phase 2 clinical trials
Lisa F Shubitz, Hien T Trinh, Robert H Perrill, et al.
Clinical Microbiology Reviews
|
July 5, 2013
Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis
Chinh Nguyen, Bridget Marie Barker, Susan Hoover, et al.
The International Journal of Lower Extremity Wounds
|
July 7, 2017
Does Everything That's Counted Count? Value of Inflammatory Markers for Following Therapy and Predicting Outcome in Diabetic Foot Infection
Eric Ong, Sumaya Farran, Michelle Salloum, et al.
American Journal of Therapeutics
|
December 3, 2019
Cefazolin Monotherapy Versus Cefazolin Plus Aminoglycosides for Antimicrobial Prophylaxis of Type III Open Fractures
Asad E Patanwala, John J Radosevich, Ian Meshay, et al.
Pharmacotherapy
|
April 12, 2020
Recommended Revisions to the National SEP-1 Sepsis Quality Measure: A commentary by the Society of Infectious Diseases Pharmacists on the Infectious Diseases Society of America Position Paper
Emily L Heil, Samuel L Aitken, David E Nix, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Journal of Cataract and Refractive Surgery
|
May 1, 2007
Prophylactic gatifloxacin therapy in prevention of bacterial keratitis in a rabbit laser in situ keratomileusis model
D Snow Slade, Jason W Friday, Robert W Snyder, et al.
The Annals of Pharmacotherapy
|
May 4, 2006
Estimation of creatinine clearance in end-stage liver disease
David E Nix, Brian L Erstad, Paul Z Nakazato, et al.
Avicenna Journal of Medicine
|
August 13, 2019
Overprescription of antibiotics in patients with community-acquired pneumonia in the intensive care unit
Rorak Hooten, Jose Luis Marquez, Kady Goldlist, et al.
American Journal of Infection Control
|
April 4, 2018
Influenza vaccine availability at urgent care centers in the state of Arizona
Norman L Beatty, Kelly M Hager, Kyle R McKeown, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
September 8, 2007
End-of-procedure cefazolin concentrations after administration for prevention of surgical-site infection
Erin Koopman, David E Nix, Brian L Erstad, et al.
The Journal of Infectious Diseases
|
January 15, 2014
Modeling nikkomycin Z dosing and pharmacology in murine pulmonary coccidioidomycosis preparatory to phase 2 clinical trials
Lisa F Shubitz, Hien T Trinh, Robert H Perrill, et al.
Clinical Microbiology Reviews
|
July 5, 2013
Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis
Chinh Nguyen, Bridget Marie Barker, Susan Hoover, et al.
The International Journal of Lower Extremity Wounds
|
July 7, 2017
Does Everything That's Counted Count? Value of Inflammatory Markers for Following Therapy and Predicting Outcome in Diabetic Foot Infection
Eric Ong, Sumaya Farran, Michelle Salloum, et al.
American Journal of Therapeutics
|
December 3, 2019
Cefazolin Monotherapy Versus Cefazolin Plus Aminoglycosides for Antimicrobial Prophylaxis of Type III Open Fractures
Asad E Patanwala, John J Radosevich, Ian Meshay, et al.
Pharmacotherapy
|
April 12, 2020
Recommended Revisions to the National SEP-1 Sepsis Quality Measure: A commentary by the Society of Infectious Diseases Pharmacists on the Infectious Diseases Society of America Position Paper
Emily L Heil, Samuel L Aitken, David E Nix, et al.
Page
of 7